Medical
Biotechnology
Pharmaceutical

Progenics Pharmaceuticals

2,349

$5.24
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-2.06%) Today
$0.00 (0.00%) As of 4:46 PM EDT after-hours

Why Robinhood?

You can buy or sell PGNX and other stocks, options, ETFs, and crypto commission-free!

About PGNX

Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. Read More The company was founded by Paul J. Maddon in 1986 and is headquartered in New York, NY.

CEO
Mark Robert Baker
Employees
79
Headquarters
New York, New York
Founded
1986
Market Cap
452.85M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.52M
High Today
$5.42
Low Today
$5.08
Open Price
$5.33
Volume
3.50M
52 Week High
$6.54
52 Week Low
$3.42

Collections

Medical
Biotechnology
Pharmaceutical
Cancer Prevention
Therapy
Health
Technology

PGNX Earnings

-$0.23
-$0.16
-$0.08
-$0.01
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 7, Pre-Market
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy PGNX

Market Price$5.24
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell PGNX stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up